How often stomach pain was reported
The US and Canadian figures come from the same two placebo-controlled trials, numbered Trial 1 and Trial 6 in the US label and named PIONEER 1 and PIONEER 8 in Canada; 1,071 people took the tablets for an average of 41.8 weeks [1][3]. Europe pools ten phase 3a trials [2].
| Source | Placebo | 7 mg | 14 mg |
|---|---|---|---|
| US PI, Table 2 [1] | 4% | 10% | 11% |
| Canadian PM, Table 3 [3] | 4.1% | 10.1% | 10.7% |
| EU SmPC 4.8 [2] | — | “Common” (1 in 100 to 1 in 10) | — |
| Upper digestive terms, US PI 6.1 [1] | Indigestion 0.6%, gastritis 0.8% | Indigestion 3%, gastritis 2% | Indigestion 0.6%, gastritis 2% |
A jump, then a plateau, and what is missing
Abdominal pain was two and a half times as common on 7 mg as on placebo, then rose by only one point on 14 mg [1]. Nausea in the same trials kept climbing steeply with strength, so the two do not travel together. The figures describe trial groups, not any one person.
The labels leave several questions open. They do not say which kinds of pain were counted, upper or lower, cramping or steady. Their timing sentence mentions nausea, vomiting and diarrhoea but not pain. And they give no stopping rate for pain alone; stopping because of any digestive reaction was 8% on 14 mg, 4% on 7 mg and 1% on placebo [1].
What adverse-event reports add
A 2024 study of 2,398 US FDA reports for semaglutide tablets ranked how strongly each problem stood out against all other drugs in the database. Pancreatitis, with 117 reports, and acute gallbladder inflammation, with 18, were among the strongest signals [4]. A broader study covering both tablets and injections found upper abdominal pain among the most frequent terms, with 827 FDA reports [5].
Signals show which problems are reported more often than expected, not how often they occur or whether the medicine caused them [4][5]. The randomised SOUL trial, for example, found adjudicated acute pancreatitis in 0.4% on oral semaglutide and 0.4% on placebo over about four years [2][3].
Three warnings that start with pain
- Pancreatitis: severe or persistent belly pain, sometimes spreading to the back, with or without nausea or vomiting [1]. In the glucose-control trials it was a serious event in 6 people on the tablets and 1 on comparators [1]. If confirmed, Canada and Europe say the medicine should not be restarted [2][3].
- Gallbladder disease: pain in the upper stomach, fever, yellow skin or eyes, or clay-coloured stools [1]. In Trial 7 (SOUL), gallstones were reported in 1.1% on 14 mg against 0.9% on placebo, and gallbladder inflammation in 1.1% against 0.7% [1].
- Severe digestive reactions and blockage: severe digestive reactions were reported by 2.0% on 14 mg, 0.6% on 7 mg and 0.3% on placebo, and bowel obstruction and ileus have been reported after approval [1]. The Rybelsus® pancreatitis and gallbladder pages cover these in depth.
Not every belly ache is the tablet
MedlinePlus lists constipation, irritable bowel syndrome, food intolerance, food poisoning and stomach flu as less serious causes, and appendicitis, ulcers, diverticulitis, kidney stones, urinary infection, hernia, endometriosis, ectopic pregnancy and an aortic aneurysm among others [6]. It describes pain spread over most of the belly as more typical of a virus, indigestion or gas; pain in one spot as more likely to come from an organ such as the appendix or gallbladder; and pain that comes in waves as typical of gallstones or kidney stones [6].
Because Rybelsus® itself causes constipation in about 1 in 20 people [1], a crampy ache with hard stools may simply reflect that.
Home care for mild pain
For mild pain, MedlinePlus suggests sipping water or other clear fluids, avoiding solid food for the first few hours, and noting that people with diabetes need to check their blood sugar often [6]. If pain is high up and comes after meals with heartburn, it mentions antacids, and suggests avoiding citrus, fatty or fried food, tomato, caffeine, alcohol and fizzy drinks [6]. It also says not to take any medicine without talking to your provider [6].
Any remedy you do take by mouth has to wait at least 30 minutes after the tablet [1], and the levels of pancreatic enzymes measured in blood rise on average on Rybelsus®: amylase by 10% to 13% and lipase by 30% to 34%, changes not seen on placebo [1]. Your clinician will interpret any such test.
Rybelsus® and Ozempic® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Severe stomach pain that does not go away, sometimes through to the back | Stop Rybelsus® and call your provider right away | Emergency | Rybelsus® Medication Guide [1] |
| Sudden, sharp belly pain, a rigid or very tender belly, or pain with chest, neck or shoulder pain | Emergency services (911) | Emergency | MedlinePlus [6] |
| Unable to pass stool, especially with vomiting, or vomiting blood or passing blood | Emergency services (911) | Emergency | MedlinePlus [6] |
| Belly pain while pregnant or possibly pregnant | Medical help right away | Emergency | MedlinePlus [6] |
| Upper stomach pain with fever, yellow skin or eyes, or clay-coloured stools | Your provider right away | Today | Rybelsus® Medication Guide [1] |
| Pain that does not improve in 24 to 48 hours, gets worse, or comes with fever | Your provider | Today | MedlinePlus [6] |
| Abdominal discomfort lasting a week or longer | Your provider at a planned visit | At your next appointment | MedlinePlus [6] |
